EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Reprint Email

China Nepstar Chain Drugstore Stock Soars (NPD)

By TheStreet Wire 04/27/12 - 12:26 PM EDT

Find out if (NPD) is in Cramer's Portfolio.

NEW YORK (TheStreet) -- Shares of China Nepstar Chain Drugstore (NYSE:NPD) have taken a tremendous swing upward. The stock is trading at $3.73 as of 12 p.m. ET, 50.4% above Thursday's closing price of $2.48. Volume is at 418,449, 8.6 times the daily average of 48,800.

China Nepstar Chain Drugstore has a market cap of $241.3 million and is part of the services sector and retail industry. Shares are up 64.2% year to date as of the close of trading on Thursday.

China Nepstar Chain Drugstore Ltd., through its subsidiaries, operates retail drugstore chain under China Nepstar name in the People's Republic of China. The company has a P/E ratio of 39.7, below the average retail industry P/E ratio of 44.1 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates China Nepstar Chain Drugstore as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full China Nepstar Chain Drugstore Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

For more information on China Nepstar Chain Drugstore Ltd. click any of the following:

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:

$2.5+ million portfolio
Large-cap and dividend focus
Intraday trade alerts from Cramer
Weekly roundups

TheStreet Quant Ratings

TRY IT FREE

New! $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:

Buy, hold, or sell recommendations for over 4,300 stocks
Unlimited research reports on your favorite stocks
A custom stock screener
Upgrade/downgrade alerts

Stocks Under $10

TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:

Model portfolio
Stocks trading below $10
Intraday trade alerts
Weekly roundups

Dividend Stock Advisor

TRY IT FREE

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:

Diversified model portfolio of dividend stocks
Alerts when market news affect the portfolio
Bi-weekly updates with exact steps to take - BUY, HOLD, SELL

Real Money Pro

TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:

Real Money + Doug Kass + 15 more Wall Street Pros
Intraday commentary & news
Ultra-actionable trading ideas

Options Profits

TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.